Moody Aldrich Partners LLC Cyma Bay Therapeutics, Inc. Transaction History

Moody Aldrich Partners LLC

  • $538 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024
SELL
$12.63 - $24.47 $815,418 - $1.58 Million
-64,562 Reduced 19.81%
261,415 $6.17 Million
Q3 2023

Nov 07, 2023
BUY
$10.86 - $17.62 $2.29 Million - $3.71 Million
210,637 Added 182.62%
325,977 $4.86 Million
Q2 2023

Jul 28, 2023
BUY
$7.47 - $10.95 $861,589 - $1.26 Million
115,340 New
115,340 $1.26 Million

Others Institutions Holding CBAY

# of Institutions
11
Shares Held
1.88M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email